33 related articles for article (PubMed ID: 303057)
1. Serial studies of autologous antibody reactivity to squamous cell carcinoma of the head and neck.
Vlock DR; Arnold B; Humpierres J; Schwartz DR; Baker SR; Krause CJ; Swanson N; Carey TE
Cancer Immunol Immunother; 1992; 34(5):329-36. PubMed ID: 1540979
[TBL] [Abstract][Full Text] [Related]
2. Long-term (5-11 years) follow-up of general immune competence in breast cancer. I. Pre-treatment levels with reference to micrometastasis.
Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
Cancer Immunol Immunother; 1986; 21(1):1-5. PubMed ID: 3632914
[TBL] [Abstract][Full Text] [Related]
3. Platelet-Lymphocyte Ratio as a Predictor of Prognosis in Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Bardash Y; Olson C; Herman W; Khaymovich J; Costantino P; Tham T
Oncol Res Treat; 2019; 42(12):665-677. PubMed ID: 31550732
[TBL] [Abstract][Full Text] [Related]
4. Immunologic responsiveness of patients with cancer: relationship to tumor type, stage and prognosis.
Humphrey LJ; Humphrey MA; Singla O; Volenec FJ
Ann Surg; 1981 May; 193(5):574-8. PubMed ID: 7235762
[TBL] [Abstract][Full Text] [Related]
5. Peripheral T gamma lymphocyte population in head and neck cancer.
Hayashi Y; Nishida T; Yoshida H; Yanagawa T; Yura Y; Furumoto N; Sato M
Cancer Immunol Immunother; 1984; 17(3):160-4. PubMed ID: 6236876
[TBL] [Abstract][Full Text] [Related]
6. Reversal of defective lymphoproliferation in postoperative patients with colon cancer.
Schindler L; Leroux M; Zimmermann GF; Betzler M; Kirchner H
J Cancer Res Clin Oncol; 1987; 113(2):166-70. PubMed ID: 3104348
[TBL] [Abstract][Full Text] [Related]
7. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J; Bitter K; Nicklisch U
J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
[TBL] [Abstract][Full Text] [Related]
8. T-cell deficiency in patients with squamous cell cancer of the head and neck.
Wanebo HJ; Jun MY; Strong EW; Oettgen H
Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
[TBL] [Abstract][Full Text] [Related]
9. [Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].
Bier J; Nicklisch U
Arch Otorhinolaryngol; 1981; 232(2):145-63. PubMed ID: 6973965
[TBL] [Abstract][Full Text] [Related]
10. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
Browder JP; Chretien PB
Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
[No Abstract] [Full Text] [Related]
11. Cellular immunity in patients with epidermoid cancer of the head and neck.
Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
[TBL] [Abstract][Full Text] [Related]
12. Immunologic evaluation and prognosis in patients with head and neck cancer.
Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
